Top Story

Adjuvant FOLFOX extended DFS in locally advanced rectal cancer

October 2, 2014

The addition of oxiliplatin to fluorouracil and leucovorin extended DFS among patients with locally advanced rectal cancer who underwent preoperative chemotherapy and total mesorectal excision, according to results of a randomized phase 2 study.

Adjuvant chemotherapy for rectal cancer is controversial, particularly among patients who underwent preoperative chemotherapy. Adjuvant chemotherapy with fluorouracil and leucovorin is commonly used.

Institution Notes

AACR presents research award

October 1, 2014
Graham A. Colditz, MD, DrPH, received the American Association for Cancer Research’s 2014 AACR Award for Outstanding Achievement in Cancer Prevention…

Just-in-Time management principles helped reduce patient wait time

October 1, 2014
Applying processes used in manufacturing to streamline patient flow can successfully reduce patient wait time and increase the confidence of residents at teaching…
figure In the Journals

Less disease education linked to greater decisional conflict in prostate cancer

October 1, 2014
Patients with less knowledge about prostate cancer are more likely to have decisional conflict and have less confidence in their decision-making effectiveness, according…
More News Headlines »

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease…
More »
Meeting News Coverage Video

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »